Masonic Cancer Center Leadership
On this page:
The Executive Committee provides leadership in the strategic planning and implementation of Masonic Cancer Center goals and objectives. It is responsible for formulating, directing, revising and implementing research, educational objectives, budget priorities, distribution of space and recruitment of faculty and staff.
Douglas Yee, M.D., Director
Jeffrey Miller, M.D., Deputy Director
Dorothy Hatsukami, Ph.D., Associate Director, Cancer Prevention and Control
David Largaespada, Ph.D., Associate Director, Basic Sciences
Badrinath Konety, M.D., M.B.A., Associate Director, Clinical Affairs
Jill Siegfried, Ph.D., Associate Director, Translational Research
Mary Sumpmann, R.N., M.S., Associate Director, Administration
Anja Bielinksy, Ph.D., Program Co-Leader, Genetic Mechanisms of Cancer
Peter Bitterman, M.D., Program Co-Leader, Genetic Mechanisms of Cancer
Edward Greeno, M.D., Director, Oncology Service Line
Kalpna Gupta, Ph.D., ProgramCo- Leader, Tumor Microenvironment
Stephen Hecht, Ph.D., Program Leader, Carcinogenesis and Chemoprevention
Anne Joseph, M.D., M.P.H., Program Co-Leader, Prevention and Etiology
Karen Kuntz, Sc.D., Program Leader, Cancer Detection, Treatment and Survivorship developing program
Carol Lange, Ph.D., Program Leader, Cell Signaling
DeAnn Lazovich, Ph.D., M.P.H. , Program Co-Leader, Prevention and Etiology
James McCarthy, Ph.D., Program Co-Leader, Tumor Microenvironment
Yoji Shimizu, Ph.D., Program Leader, Immunology
John Wagner, M.D., Program Co-Leader, Transplant Biology and Therapy
Daniel Weisdorf, M.D., Program Co-Leader, Transplant Biology and Therapy
Susan Collins, Finance and Operations Director
Jean Jacoby, Executive Assistant for Administration
Mary Sumpmann, R.N., M.S., Associate Director for Administration
Gerry O'Sullivan, M.V.B., Ph.D., Diplomate A.C.V.P. & ECVP, Comparative Pathology
Anindya Bagchi, Ph.D., Mouse Genetics Laboratory (Co-Director)
Stephen S. Hecht, Ph.D., Analytical Biochemistry
Betsy Hirsch, Ph.D., Cytogenomics
David A. Largaespada, Ph.D., Mouse Genetics Laboratory (Co-Director)
Chap Le, Ph.D., Biostatistics and Informatics
Christopher Pennell, Ph.D., Flow Cytometry
Brenda Weigel, M.D., Clinical Trials Office Medical Director
Amy Skubitz, Ph.D., Tissue Procurement Facility
Michael Verneris, M.D., Translational Cell Therapy
The Council of Deans and Directors advises the Director and assists in efforts to achieve goals and objectives, discusses advocacy for development and operations, and provides oversight of finances.
Aaron Friedman , M.D., Chair, Senior Vice President, Academic Health Center; Dean, Medical School
Trevor Ames, D.V.M., Interim Dean, College of Veterinary
Steven L. Crouch, Ph.D., Dean, Institute of Technology
Connie White Delaney, Ph.D., R.N., Dean, School of Nursing
Robert Elde, Ph.D., Dean, College of Biological Sciences
John Finnegan, Ph.D., Dean, School of Public Health
Judith Buchanan, D.M.D., Ph.D., Interim Dean, School of Dentistry
Marilyn Speedie, Ph.D., Dean, College of Pharmacy
Douglas Yee, M.D., Director, Masonic Cancer Center
Mary Sumpmann, R.N., M.S., (ex officio) Associate Director for Administration
The External Scientific Advisory Board, which consists of national experts in basic, clinical and population-based research, participates in an annual external scientific review of the Masonic Cancer Center's activities.
David Beer, Ph.D., Professor of Surgery and Radiation Oncology, Co-director, Cancer Genetics Program, University of Michigan Comprehensive Cancer Center
Irwin Bernstein, M.D., Hematology-Oncology Division Head, Fred Hutchinson Cancer Research Center, Seattle
Smita Bhatia, M.D., M.P.H., Chair and Professor, Population Sciences City of Hope National Medical Center
Melissa Bondy, Ph.D., Professor, Department of Epidemiology, M.D. Anderson Cancer Center, Houston
Lisa Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science.
Professor and Chair, Cell & Developmental Biology, Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University
Kevin Cullen, M.D., Director, University of Maryland Greenebaum Cancer Center, Baltimore
Michael Darling, M.H.A, Associate Director for Administration, Melvin and Bren Simon Cancer Center, Indiana University
Laurence Hurley, Ph.D., Howard J. Schaffer Endowed Chair in Pharmaceutical Sciences, College of Pharmacy, The University of Arizona
Thomas Kensler, Ph.D., Johns Hopkins Bloomberg School of Public Health, Baltimore
Kimberly Leslie, M.D., Professor and Head, Department of Obstetrics and Gynecology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City
James Mulè, Ph.D., Associate Center Director, Translational Science & Tehncology Development, H. Lee Moffitt Cancer & Research Institute, Tampa
Vito Quaranta, M.D., Professor of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville
Mace Rothenberg, M.D., Senior Vice President, Clinical Development and Medical Affairs, Pfizer Oncology
Glorian Sorensen, Ph.D., M.P.H., Director, Center for Community-Based Research, Dana-Farber Cancer Institute, Boston
George Wilding, M.D., Director, University of Wisconsin Paul D. Carbone Comprehensive Cancer Center, Madison
The Community Advisory Board advises and supports the leadership in mission, programmatic direction, community interactions, outreach, public relations, and advocacy.
Thomas Amatruda, M.D.
Ruth Bachman (Chair)
Stuart Bloom, M.D.
John H. Brown, M.D. (Emeritus)
Marilyn Tickle Bryant
Wilhelmina Holder, M.D.
Blake Johnson, M.D.
Phyllis Kahn, Ph.D.
James Krook, Ph.D.
Irving Lerner, M.D.
Dennis W. Schulstad
George "Skip" Thaler
Emily Anne Tuttle
Harold Windschitl, M.D.
Douglas Yee, M.D.*